Explore the implications of GLP-1 drugs in managing India's obesity crisis as experts warn of potential misuse and health ...

Palatin Technologies, Inc. (OTCQB: PTNT), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today ...